Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 295
Filtrar
1.
Virus Res ; 344: 199368, 2024 06.
Artigo em Inglês | MEDLINE | ID: mdl-38588924

RESUMO

Several viruses are now known to code for deubiquitinating proteases in their genomes. Ubiquitination is an essential post-translational modification of cellular substrates involved in many processes in the cell, including in innate immune signalling. This post-translational modification is regulated by the ubiquitin conjugation machinery, as well as various host deubiquitinating enzymes. The conjugation of ubiquitin chains to several innate immune related factors is often needed to induce downstream signalling, shaping the antiviral response. Viral deubiquitinating proteins, besides often having a primary function in the viral replication cycle by cleaving the viral polyprotein, are also able to cleave ubiquitin chains from such host substrates, in that way exerting a function in innate immune evasion. The presence of viral deubiquitinating enzymes has been firmly established for numerous animal-infecting viruses, such as some well-researched and clinically important nidoviruses, and their presence has now been confirmed in several plant viruses as well. Viral proteases in general have long been highlighted as promising drug targets, with a current focus on small molecule inhibitors. In this review, we will discuss the range of viral deubiquitinating proteases known to date, summarise the various avenues explored to inhibit such proteases and discuss novel strategies and models intended to inhibit and study these specific viral enzymes.


Assuntos
Enzimas Desubiquitinantes , Enzimas Desubiquitinantes/metabolismo , Enzimas Desubiquitinantes/antagonistas & inibidores , Enzimas Desubiquitinantes/genética , Humanos , Proteases Virais/metabolismo , Processamento de Proteína Pós-Traducional , Ubiquitinação , Animais , Replicação Viral , Antivirais/farmacologia , Inibidores de Proteases/farmacologia , Vírus/efeitos dos fármacos , Vírus/enzimologia , Proteínas Virais/metabolismo , Proteínas Virais/genética , Ubiquitina/metabolismo , Imunidade Inata
2.
Enzymes ; 49: 315-354, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34696837

RESUMO

The treatment of viral infections remains challenging, in particular in the face of emerging pathogens. Broad-spectrum antiviral drugs could potentially be used as a first line of defense. The RNA-dependent RNA polymerase (RdRp) of RNA viruses serves as a logical target for drug discovery and development efforts. Herein we discuss compounds that target RdRp of poliovirus, hepatitis C virus, influenza viruses, respiratory syncytial virus, and the growing data on coronaviruses. We focus on nucleotide analogs and mechanisms of action and resistance.


Assuntos
Antivirais/farmacologia , Nucleotídeos/farmacologia , RNA Polimerase Dependente de RNA/antagonistas & inibidores , Proteínas do Complexo da Replicase Viral/antagonistas & inibidores , Vírus/enzimologia , Replicação Viral
3.
Int J Mol Sci ; 22(9)2021 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-33922750

RESUMO

The ubiquitin (Ub) proteasome system (UPS) plays a pivotal role in regulation of numerous cellular processes, including innate and adaptive immune responses that are essential for restriction of the virus life cycle in the infected cells. Deubiquitination by the deubiquitinating enzyme, deubiquitinase (DUB), is a reversible molecular process to remove Ub or Ub chains from the target proteins. Deubiquitination is an integral strategy within the UPS in regulating survival and proliferation of the infecting virus and the virus-invaded cells. Many viruses in the infected cells are reported to encode viral DUB, and these vial DUBs actively disrupt cellular Ub-dependent processes to suppress host antiviral immune response, enhancing virus replication and thus proliferation. This review surveys the types of DUBs encoded by different viruses and their molecular processes for how the infecting viruses take advantage of the DUB system to evade the host immune response and expedite their replication.


Assuntos
Enzimas Desubiquitinantes/metabolismo , Interações Hospedeiro-Patógeno/imunologia , Imunidade Inata/imunologia , Ubiquitina/metabolismo , Proteínas Virais/metabolismo , Viroses/imunologia , Vírus/enzimologia , Animais , Enzimas Desubiquitinantes/química , Humanos , Evasão da Resposta Imune , Estágios do Ciclo de Vida , Ubiquitinação , Proteínas Virais/química , Viroses/enzimologia , Viroses/virologia , Replicação Viral , Vírus/imunologia
4.
Cell ; 184(6): 1604-1620, 2021 03 18.
Artigo em Inglês | MEDLINE | ID: mdl-33740455

RESUMO

Historically, emerging viruses appear constantly and have cost millions of human lives. Currently, climate change and intense globalization have created favorable conditions for viral transmission. Therefore, effective antivirals, especially those targeting the conserved protein in multiple unrelated viruses, such as the compounds targeting RNA-dependent RNA polymerase, are urgently needed to combat more emerging and re-emerging viruses in the future. Here we reviewed the development of antivirals with common targets, including those against the same protein across viruses, or the same viral function, to provide clues for development of antivirals for future epidemics.


Assuntos
Antivirais/uso terapêutico , Doenças Transmissíveis Emergentes/tratamento farmacológico , Doenças Transmissíveis Emergentes/epidemiologia , Terapia de Alvo Molecular/métodos , Pandemias , Viroses/tratamento farmacológico , Viroses/epidemiologia , Vírus/enzimologia , Animais , Antivirais/farmacologia , Doenças Transmissíveis Emergentes/virologia , Humanos , RNA Polimerase Dependente de RNA/antagonistas & inibidores , Proteínas do Envelope Viral/antagonistas & inibidores , Viroses/virologia , Internalização do Vírus/efeitos dos fármacos
5.
Nutrients ; 12(9)2020 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-32825564

RESUMO

This review summarizes the latest advancements in phytochemicals as functional antiviral agents. We focused on flavonoids, like apigenin, vitexin, quercetin, rutin and naringenin, which have shown a wide range of biological effects including antiviral activities. The molecular mechanisms of their antiviral effects mainly consist in the inhibition of viral neuraminidase, proteases and DNA/RNA polymerases, as well as in the modification of various viral proteins. Mixtures of different flavonoids or combination of flavonoids with antiviral synthetic drugs provide an enhancement of their antiviral effects. Recent strategies in drug delivery significantly contribute to overcoming the low bioavailability of flavonoids. Frequent viral infections worldwide have led to the need for new effective antiviral agents, which can be identified among the various phytochemicals. In this light, screening the antiviral activities of a cocktail of flavonoids would be advantageous in order to prevent viral infections and improve current antiviral therapies.


Assuntos
Antivirais , Sistemas de Liberação de Medicamentos , Flavonoides/administração & dosagem , Flavonoides/farmacologia , Apigenina/química , Apigenina/farmacologia , Disponibilidade Biológica , Combinação de Medicamentos , Avaliação Pré-Clínica de Medicamentos , Sinergismo Farmacológico , Flavanonas/química , Flavanonas/farmacologia , Flavonoides/química , Flavonoides/farmacocinética , Humanos , Neuraminidase/antagonistas & inibidores , Quercetina/química , Quercetina/farmacologia , Rutina/química , Rutina/farmacologia , Inibidores de Protease Viral , Proteínas Virais/metabolismo , Viroses/tratamento farmacológico , Viroses/prevenção & controle , Viroses/virologia , Vírus/enzimologia , Vírus/metabolismo
6.
Molecules ; 25(15)2020 Jul 26.
Artigo em Inglês | MEDLINE | ID: mdl-32722555

RESUMO

In this study, the chemical diversity of polyphenols in Iris lactea var. chinensis seeds was identified by combined MS/MS-NMR analysis. Based on the annotated chemical profile, the isolation of stilbene oligomers was conducted, and consequently, stilbene oligomers (1-10) were characterized. Of these, compounds 1 and 2 are previously undescribed stilbene dimer glycoside (1) and tetramer glycoside (2), respectively. Besides, to evaluate this plant seed as a rich source of stilbene oligomers, we quantified three stilbene oligomers of I. lactea var. chinensis seeds. The contents of three major stilbene oligomers-trans-ε-viniferin (3), vitisin A (6), and vitisin B (9)-in I. lactea var. chinensis seeds were quantified as 2.32 (3), 4.95 (6), and 1.64 (9) mg/g dry weight (DW). All the isolated compounds were tested for their inhibitory activities against influenza neuraminidase. Compound 10 was found to be active with the half maximal inhibitory concentration (IC50) values at 4.76 µM. Taken together, it is concluded that I. lactea var. chinensis seed is a valuable source of stilbene oligomers with a human health benefit.


Assuntos
Gênero Iris/química , Neuraminidase/antagonistas & inibidores , Polifenóis/química , Vírus/efeitos dos fármacos , Humanos , Raízes de Plantas/química , Polifenóis/farmacologia , Sementes/química , Espectrometria de Massas em Tandem , Vírus/enzimologia
7.
Elife ; 92020 04 27.
Artigo em Inglês | MEDLINE | ID: mdl-32338598

RESUMO

Cyclic nucleotide second messengers are increasingly implicated in prokaryotic anti-viral defence systems. Type III CRISPR systems synthesise cyclic oligoadenylate (cOA) upon detecting foreign RNA, activating ancillary nucleases that can be toxic to cells, necessitating mechanisms to remove cOA in systems that operate via immunity rather than abortive infection. Previously, we demonstrated that the Sulfolobus solfataricus type III-D CRISPR complex generates cyclic tetra-adenylate (cA4), activating the ribonuclease Csx1, and showed that subsequent RNA cleavage and dissociation acts as an 'off-switch' for the cyclase activity. Subsequently, we identified the cellular ring nuclease Crn1, which slowly degrades cA4 to reset the system (Rouillon et al., 2018), and demonstrated that viruses can subvert type III CRISPR immunity by means of a potent anti-CRISPR ring nuclease variant AcrIII-1. Here, we present a comprehensive analysis of the dynamic interplay between these enzymes, governing cyclic nucleotide levels and infection outcomes in virus-host conflict.


Assuntos
Sistemas CRISPR-Cas , Interações entre Hospedeiro e Microrganismos , Nucleotídeos Cíclicos/metabolismo , Transdução de Sinais , Vírus/enzimologia , Vírus/genética , Escherichia coli/enzimologia , Escherichia coli/genética , Sulfolobus solfataricus/genética , Sulfolobus solfataricus/metabolismo
9.
Nature ; 577(7791): 572-575, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31942067

RESUMO

The CRISPR system in bacteria and archaea provides adaptive immunity against mobile genetic elements. Type III CRISPR systems detect viral RNA, resulting in the activation of two regions of the Cas10 protein: an HD nuclease domain (which degrades viral DNA)1,2 and a cyclase domain (which synthesizes cyclic oligoadenylates from ATP)3-5. Cyclic oligoadenylates in turn activate defence enzymes with a CRISPR-associated Rossmann fold domain6, sculpting a powerful antiviral response7-10 that can drive viruses to extinction7,8. Cyclic nucleotides are increasingly implicated in host-pathogen interactions11-13. Here we identify a new family of viral anti-CRISPR (Acr) enzymes that rapidly degrade cyclic tetra-adenylate (cA4). The viral ring nuclease AcrIII-1 is widely distributed in archaeal and bacterial viruses and in proviruses. The enzyme uses a previously unknown fold to bind cA4 specifically, and a conserved active site to rapidly cleave this signalling molecule, allowing viruses to neutralize the type III CRISPR defence system. The AcrIII-1 family has a broad host range, as it targets cA4 signalling molecules rather than specific CRISPR effector proteins. Our findings highlight the crucial role of cyclic nucleotide signalling in the conflict between viruses and their hosts.


Assuntos
Sistemas CRISPR-Cas/imunologia , Endonucleases/metabolismo , Interações entre Hospedeiro e Microrganismos/imunologia , Sulfolobus/virologia , Proteínas Virais/metabolismo , Vírus/enzimologia , Nucleotídeos de Adenina/química , Nucleotídeos de Adenina/metabolismo , Proteínas Associadas a CRISPR/química , Proteínas Associadas a CRISPR/metabolismo , DNA Viral/metabolismo , Endonucleases/química , Modelos Moleculares , Nucleotídeos Cíclicos/química , Nucleotídeos Cíclicos/metabolismo , Oligorribonucleotídeos/química , Oligorribonucleotídeos/metabolismo , Filogenia , Transdução de Sinais , Sulfolobus/genética , Sulfolobus/imunologia , Sulfolobus/metabolismo , Proteínas Virais/química , Proteínas Virais/classificação , Vírus/imunologia
10.
Biosensors (Basel) ; 11(1)2020 Dec 31.
Artigo em Inglês | MEDLINE | ID: mdl-33396519

RESUMO

The United States Centers for Disease Control and Prevention considers saliva contact the lead transmission means of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19). Saliva droplets or aerosols expelled by heavy breathing, talking, sneezing, and coughing may carry this virus. People in close distance may be exposed directly or indirectly to these droplets, especially those droplets that fall on surrounding surfaces and people may end up contracting COVID-19 after touching the mucosa tissue on their faces. It is of great interest to quickly and effectively detect the presence of SARS-CoV-2 in an environment, but the existing methods only work in laboratory settings, to the best of our knowledge. However, it may be possible to detect the presence of saliva in the environment and proceed with prevention measures. However, detecting saliva itself has not been documented in the literature. On the other hand, many sensors that detect different organic components in saliva to monitor a person's health and diagnose different diseases that range from diabetes to dental health have been proposed and they may be used to detect the presence of saliva. This paper surveys sensors that detect organic and inorganic components of human saliva. Humidity sensors are also considered in the detection of saliva because a large portion of saliva is water. Moreover, sensors that detect infectious viruses are also included as they may also be embedded into saliva sensors for a confirmation of the virus' presence. A classification of sensors by their working principle and the substance they detect is presented. This comparison lists their specifications, sample size, and sensitivity. Indications of which sensors are portable and suitable for field application are presented. This paper also discusses future research and challenges that must be resolved to realize practical saliva sensors. Such sensors may help minimize the spread of not only COVID-19 but also other infectious diseases.


Assuntos
Monitoramento Biológico/instrumentação , COVID-19/prevenção & controle , SARS-CoV-2/isolamento & purificação , Saliva/química , Saliva/virologia , Monitoramento Biológico/métodos , COVID-19/enzimologia , COVID-19/etiologia , COVID-19/imunologia , Doenças Transmissíveis/enzimologia , Doenças Transmissíveis/etiologia , Doenças Transmissíveis/imunologia , Doenças Transmissíveis/virologia , Humanos , Vírus da Influenza A Subtipo H1N1/química , Vírus da Influenza A Subtipo H1N1/enzimologia , Vírus da Influenza A Subtipo H1N1/imunologia , Vírus da Influenza A Subtipo H1N1/isolamento & purificação , SARS-CoV-2/química , SARS-CoV-2/imunologia , Saliva/enzimologia , Saliva/imunologia , Vírus/química , Vírus/enzimologia , Vírus/imunologia , Vírus/isolamento & purificação
11.
Gene ; 723: 144134, 2020 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-31589960

RESUMO

Viral kinases are known to undergo autophosphorylation and also phosphorylate viral and host substrates. Viral kinases have been implicated in various diseases and are also known to acquire host kinases for mimicking cellular functions and exhibit virulence. Although substantial analyses have been reported in the literature on diversity of viral kinases, there is a gap in the understanding of sequence and structural similarity among kinases from different classes of viruses. In this study, we performed a comprehensive analysis of protein kinases encoded in viral genomes. Homology search methods have been used to identify kinases from 104,282 viral genomic datasets. Serine/threonine and tyrosine kinases are identified only in 390 viral genomes. Out of seven viral classes that are based on nature of genetic material, only viruses having double-stranded DNA and single-stranded RNA retroviruses are found to encode kinases. The 716 identified protein kinases are classified into 63 subfamilies based on their sequence similarity within each cluster, and sequence signatures have been identified for each subfamily. 11 clusters are well represented with at least 10 members in each of these clusters. Kinases from dsDNA viruses, Phycodnaviridae which infect green algae and Herpesvirales that infect vertebrates including human, form a major group. From our analysis, it has been observed that the protein kinases in viruses belonging to same taxonomic lineages form discrete clusters and the kinases encoded in alphaherpesvirus form host-specific clusters. A comprehensive sequence and structure-based analysis enabled us to identify the conserved residues or motifs in kinase catalytic domain regions across all viral kinases. Conserved sequence regions that are specific to a particular viral kinase cluster and the kinases that show close similarity to eukaryotic kinases were identified by using sequence and three-dimensional structural regions of eukaryotic kinases as reference. The regions specific to each viral kinase cluster can be used as signatures in the future in classifying uncharacterized viral kinases. We note that kinases from giant viruses Marseilleviridae have close similarity to viral oncogenes in the functional regions and in putative substrate binding regions indicating their possible role in cancer.


Assuntos
Proteínas Quinases/química , Proteínas Quinases/genética , Vírus/classificação , Domínio Catalítico , Biologia Computacional/métodos , Bases de Dados de Proteínas , Variação Genética , Fosforilação , Filogenia , Proteínas Quinases/metabolismo , Homologia de Sequência de Aminoácidos , Proteínas Virais/química , Proteínas Virais/genética , Proteínas Virais/metabolismo , Fatores de Virulência/química , Fatores de Virulência/genética , Fatores de Virulência/metabolismo , Vírus/enzimologia , Vírus/patogenicidade
12.
Viruses ; 11(12)2019 11 27.
Artigo em Inglês | MEDLINE | ID: mdl-31783527

RESUMO

The sphingosine 1-phosphate (S1P) metabolic pathway is a dynamic regulator of multiple cellular and disease processes. Identification of the immune regulatory role of the sphingosine analog FTY720 led to the development of the first oral therapy for the treatment of an autoimmune disease, multiple sclerosis. Furthermore, inhibitors of sphingosine kinase (SphK), which mediate S1P synthesis, are being evaluated as a therapeutic option for the treatment of cancer. In conjunction with these captivating discoveries, S1P and S1P-metabolizing enzymes have been revealed to display vital functions during virus infections. For example, S1P lyase, which is known for metabolizing S1P, inhibits influenza virus replication by promoting antiviral type I interferon innate immune responses. In addition, both isoforms of sphingosine kinase have been shown to regulate the replication or pathogenicity of many viruses. Pro- or antiviral activities of S1P-metabolizing enzymes appear to be dependent on diverse virus-host interactions and viral pathogenesis. This review places an emphasis on summarizing the functions of S1P-metabolizing enzymes during virus infections and discusses the opportunities for designing pioneering antiviral drugs by targeting these host enzymes.


Assuntos
Aldeído Liases/imunologia , Imunidade Inata , Lisofosfolipídeos/metabolismo , Fosfotransferases (Aceptor do Grupo Álcool)/imunologia , Esfingosina/análogos & derivados , Viroses/imunologia , Vírus/enzimologia , Aldeído Liases/antagonistas & inibidores , Antivirais/imunologia , Antivirais/uso terapêutico , Interações Hospedeiro-Patógeno , Humanos , Interferon Tipo I/uso terapêutico , Fosfotransferases (Aceptor do Grupo Álcool)/antagonistas & inibidores , Esfingosina/metabolismo , Viroses/virologia , Replicação Viral , Vírus/genética , Vírus/imunologia , Vírus/patogenicidade
13.
Biochimie ; 166: 4-18, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31377195

RESUMO

The distribution of all peptidase homologues across all phyla of organisms was analysed to determine within which kingdom each of the 271 families originated. No family was found to be ubiquitous and even peptidases thought to be essential for life, such as signal peptidase and methionyl aminopeptides are missing from some clades. There are 33 peptidase families common to archaea, bacteria and eukaryotes and are assumed to have originated in the last universal common ancestor (LUCA). These include peptidases with different catalytic types, exo- and endopeptidases, peptidases with different tertiary structures and peptidases from different families but with similar structures. This implies that the different catalytic types and structures pre-date LUCA. Other families have had their origins in the ancestors of viruses, archaea, bacteria, fungi, plants and animals, and a number of families have had their origins in the ancestors of particular phyla. The evolution of peptidases is compared to recent hypotheses about the evolution of organisms.


Assuntos
Archaea/enzimologia , Bactérias/enzimologia , Eucariotos/enzimologia , Peptídeo Hidrolases , Vírus/enzimologia , Animais , Bases de Dados de Proteínas , Evolução Molecular , Transferência Genética Horizontal , Peptídeo Hidrolases/classificação , Peptídeo Hidrolases/genética , Filogenia
14.
Viruses ; 11(8)2019 08 13.
Artigo em Inglês | MEDLINE | ID: mdl-31412589

RESUMO

Nucleic acid polymerases are essential enzymes that replicate the genomes of both RNA and DNA viruses. These enzymes are generally encoded by viruses themselves so as to provide biochemical functions and control elements that differ from those of the host cell polymerases. The core active site structure used by all replicative polymerases is highly conserved and composed of two key aspartate residues from the conserved motifs A and C, but beyond this there is significant divergence among structures. These differences can make it difficult to select which portions of structures to align for comparisons, yet there are extended structural similarities within different groups of viral polymerases that should clearly be considered to generate optimal alignments. This manuscript describes a comprehensive structure-based superposition of every viral polymerase structure solved thus far based on an alignment-tree approach wherein aligned regions grow in complexity as similarity among polymerases increases. The result is a set of 646 structures that have been aligned into a single common orientation. This provides a convenient resource for directly comparing viral polymerases and illustrating structural conservation among them. It also sets the stage for detailed bioinformatics analysis to further assess common structural features. The full set of protein data bank (PDB) formatted files is publicly available at http://www.zenodo.org/communities/pols/.


Assuntos
DNA Polimerase Dirigida por DNA/química , Proteínas Virais/química , Vírus/enzimologia , Biologia Computacional , DNA Polimerase Dirigida por DNA/genética , DNA Polimerase Dirigida por DNA/metabolismo , Modelos Moleculares , Filogenia , Proteínas Virais/genética , Proteínas Virais/metabolismo , Vírus/química , Vírus/classificação , Vírus/genética
15.
Proc Natl Acad Sci U S A ; 116(25): 12343-12352, 2019 06 18.
Artigo em Inglês | MEDLINE | ID: mdl-31167942

RESUMO

Genes encoding cytochrome P450 (CYP; P450) enzymes occur widely in the Archaea, Bacteria, and Eukarya, where they play important roles in metabolism of endogenous regulatory molecules and exogenous chemicals. We now report that genes for multiple and unique P450s occur commonly in giant viruses in the Mimiviridae, Pandoraviridae, and other families in the proposed order Megavirales. P450 genes were also identified in a herpesvirus (Ranid herpesvirus 3) and a phage (Mycobacterium phage Adler). The Adler phage P450 was classified as CYP102L1, and the crystal structure of the open form was solved at 2.5 Å. Genes encoding known redox partners for P450s (cytochrome P450 reductase, ferredoxin and ferredoxin reductase, and flavodoxin and flavodoxin reductase) were not found in any viral genome so far described, implying that host redox partners may drive viral P450 activities. Giant virus P450 proteins share no more than 25% identity with the P450 gene products we identified in Acanthamoeba castellanii, an amoeba host for many giant viruses. Thus, the origin of the unique P450 genes in giant viruses remains unknown. If giant virus P450 genes were acquired from a host, we suggest it could have been from an as yet unknown and possibly ancient host. These studies expand the horizon in the evolution and diversity of the enormously important P450 superfamily. Determining the origin and function of P450s in giant viruses may help to discern the origin of the giant viruses themselves.


Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Evolução Molecular , Família Multigênica , Vírus/enzimologia , Sistema Enzimático do Citocromo P-450/genética
16.
Adv Exp Med Biol ; 1142: 115-129, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31102244

RESUMO

Lytic polysaccharide monooxygenases (LPMOs) are copper-dependent enzymes that catalyze the cleavage of 1,4-glycosidic bonds various plant cell wall polysaccharides and chitin. In contrast to glycoside hydrolases, LPMOs are active on the crystalline regions of polysaccharides and thus synergize with hydrolytic enzymes. This synergism leads to an overall increase in the biomass-degradation activity of enzyme mixtures. Chitin-active LPMOs were discovered in 2010 and are currently classified in families AA10, AA11, and AA15 of the Carbohydrate-Active enZYmes database, which include LPMOs from bacteria, fungi, insects, and viruses. LPMOs have become important enzymes both industrially and scientifically and, in this chapter, we provide a brief introduction to chitin-active LPMOs including a summary of the 20+ chitin-active LPMOs that have been characterized so far. Then, we describe their structural features, catalytic mechanism, and appended carbohydrate modules. Finally, we show how chitin-active LPMOs can be used to perform chemo-enzymatic modification of chitin substrates.


Assuntos
Quitina/química , Oxigenases de Função Mista , Animais , Bactérias/enzimologia , Parede Celular , Fungos/enzimologia , Glicosídeo Hidrolases , Insetos/enzimologia , Vírus/enzimologia
17.
Methods Enzymol ; 618: 357-387, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30850060

RESUMO

Protein (poly-)ubiquitination is a posttranslational modification that plays a key role in almost all cellular processes. It involves the installment of either single ubiquitin (Ub) moieties or one of eight different polyUb linkage types, each giving a distinct cellular outcome. Deubiquitinating enzymes (DUBs) reverse Ub signaling by disassembly of one or multiple poly-Ub chain types and their malfunction is often associated with human disease. The Ub system displays significant crosstalk with structurally homologous ubiquitin-like proteins (Ubls), including SUMO, Nedd8, and ISG15. This can be seen with the existence of heterogeneous chains made from Ub-Ubl mixtures as well as the proteolytic cross reactivity displayed by several DUBs toward other Ubl systems. In addition, numerous pathogens have been found to encode Ub(l)-ligases and deconjugating enzymes in order to facilitate infection and fight the host immune response. Studying the activity of DUBs and Ubl-specific proteases, both human as well as pathogen-derived, gives fundamental insights into their physiological roles. Activity-based probes (ABPs) have proven to be valuable tools to achieve this, as they report on enzyme activities by making a (often irreversible) covalent complex, rather than on their relative abundance. In this chapter, we explain the potential of ABPs to assess substrate preferences, structural features, and activity of Ub and Ubl deconjugating enzymes. We further demonstrate the practical use of ABPs to (1) characterize the activity of viral proteases toward Ub and Ubls and (2) to gain more insight in the structural determinants of substrate preference of DUBs.


Assuntos
Enzimas Desubiquitinantes/metabolismo , Ubiquitinas/metabolismo , Animais , Ensaios Enzimáticos/métodos , Humanos , Inteínas , Sondas Moleculares/química , Sondas Moleculares/metabolismo , Peptídeo Hidrolases/metabolismo , Especificidade por Substrato , Ubiquitina/metabolismo , Vírus/enzimologia
18.
Viruses ; 11(3)2019 03 05.
Artigo em Inglês | MEDLINE | ID: mdl-30841520

RESUMO

Arboviruses continue to be a significant global health concern. The unbiased metagenomic analyses of mosquito-borne and mosquito-specific viruses are useful to understand viral diversity and for the surveillance of pathogens of medical and veterinary importance. Metagenomic analysis was conducted on 6368 mosquitoes (736 pools), covering 16 species from 18 locations throughout the Republic of Korea (ROK) in 2016. In this report, we describe three viruses detected in a single pool of Aedes vexans nipponii collected at Yongsan U.S. Army Garrison, located in a densely populated district of Seoul, the ROK. The three novel viruses, designated as Yongsan bunyavirus 1 (YBV1), Yongsan picorna-like virus 3 (YPLV3) and Yongsan sobemo-like virus 1 (YSLV1), share sequence and structural characteristics with members belonging to the family Bunyaviridae, order Picornavirales, and family Solemoviridae, with shared RNA-dependent RNA polymerase (RdRp) amino acid identities of 40%, 42% and 86%, respectively. The real-time reverse transcription and polymerase chain reaction (RT-PCR) of 3493 Aedes vexans nipponii (257 pools) showed a high prevalence of YBV1 and YSLV1 viruses, which were present in 65% and 62% of tested pools, respectively. This study highlighted the utility of a metagenomic sequencing approach for arbovirus discovery and for a better understanding of the virome of potential medically relevant vectors.


Assuntos
Aedes/virologia , Metagenômica , Mosquitos Vetores/virologia , Vírus/classificação , Animais , Arbovírus/classificação , Flavivirus/classificação , Sequenciamento de Nucleotídeos em Larga Escala , Orthobunyavirus/classificação , Prevalência , RNA Polimerase Dependente de RNA/genética , República da Coreia , Análise de Sequência de DNA , Vírus/enzimologia
20.
Future Med Chem ; 11(2): 137-154, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-30648904

RESUMO

Acyclic nucleoside phosphonates represent a well-defined class of clinically used nucleoside analogs. All acyclic nucleoside phosphonates need intracellular phosphorylation before they can bind viral DNA polymerases. Recently, a novel class of alpha-carboxynucleoside phosphonates have been designed to mimic the natural 2'-deoxynucleotide 5'-triphosphate substrates of DNA polymerases. They contain a carboxyl group in the phosphonate moiety linked to the nucleobase through a cyclic or acyclic bridge. Alpha-carboxynucleoside phosphonates act as viral DNA polymerase inhibitors without any prior requirement of metabolic conversion. Selective inhibitory activity against retroviral reverse transcriptase and herpesvirus DNA polymerases have been demonstrated. These compounds have a unique mechanism of inhibition of viral DNA polymerases, and provide possibilities for further modifications to optimize and fine tune their antiviral DNA polymerase spectrum.


Assuntos
Antivirais/química , Antivirais/farmacologia , Inibidores da Síntese de Ácido Nucleico/química , Inibidores da Síntese de Ácido Nucleico/farmacologia , Nucleosídeos/análogos & derivados , Nucleosídeos/farmacologia , Organofosfonatos/química , Organofosfonatos/farmacologia , Animais , DNA Polimerase Dirigida por DNA , Descoberta de Drogas , Exodesoxirribonucleases/antagonistas & inibidores , Herpes Simples/tratamento farmacológico , Humanos , Modelos Moleculares , Inibidores da Transcriptase Reversa/química , Inibidores da Transcriptase Reversa/farmacologia , Proteínas Virais/antagonistas & inibidores , Viroses/tratamento farmacológico , Vírus/efeitos dos fármacos , Vírus/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...